Immunoprotein Diagnostic Testing Market Size | Companies
The global immunoprotein diagnostic testing market size was valued at USD 9.18 billion in 2023 and is anticipated to reach around USD 19.45 billion by 2033, growing at a CAGR of 7.8% from 2024 to 2033.
The market growth including growing demand for personalized medicine, and technological advancements. High prevalence of chronic disorders, such as infectious diseases, cancer, cardiovascular disease, obesity, diabetes, and rheumatoid arthritis has led to the growth of immunoprotein diagnostic testing products.
According to the World Health Organization (WHO), 35 million new cancer cases are predicted in 2050. Due to this, fast and accurate diagnosis of such chronic diseases is important to reduce high mortality and immunoprotein diagnostic testing devices & reagents have proved to be highly effective in the early detection of chronic diseases.
Research and development in technology have introduced new devices and technology in the immunoprotein diagnostic testing market. Increased investment by private players and government initiatives are driving the market growth.
| Report Attribute | Details |
| Market Size in 2024 | USD 9.90 Billion |
| Market Size by 2033 | USD 19.45 Billion |
| Growth Rate From 2024 to 2033 | CAGR of 7.8% |
| Base Year | 2023 |
| Forecast Period | 2024 to 2033 |
| Segments Covered | Test, Application, Technology, End Use, Distribution Channel and Region |
| Market Analysis (Terms Used) | Value (US$ Million/Billion) or (Volume/Units) |
| Report Coverage | Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Key Companies Profiled | Agilent Technologies, Inc.; Danaher Corporation; Thermo Fisher Scientific Inc.; PerkinElmer Inc.; Bio-Rad Laboratories, Inc.; Aurora Biomed Inc.; Tecan Trading AG; Promega Corporation; Charles River Laboratories; Creative Biolabs. |
The immunoglobulin diagnostic tests segment dominated the market and accounted for a share of 26.10% in 2023. Immunoglobin is Y shaped molecule which are produced by plasma cells. It has mainly three functions such as neutralizing foreign invaders, coating foreign invaders and stimulating the immune system. The efficiency of immunoglobulin diagnostic test to help healthcare professionals to gather information about immune system of the patient.
The C-Reactive Protein (CRP) diagnostic tests segment is expected to grow at a CAGR of 8.1% over the forecast period. This is owing to an increase in the use of CRP diagnostic test by healthcare professionals to find inflammation caused by various conditions such as infections and autoimmune disorders. CRP is a protein produced by the liver and when there is inflammation due to infection, disease or injury CRP levels increases.
The infectious disease testing segment held the largest share of 25.19% in 2023 owing to the rise of infectious diseases such as HIV1, HIV2, Hepatitis B, Hepatitis C and Malaria. Rapid diagnosis of infectious diseases, shift from centralized testing in laboratories to decentralized testing in different point of care testing, and technological advancements have improved accuracy, speed and accessibility in this segment.
The oncology testing segment in the global immunoprotein diagnostic testing market is expected to grow at a significant CAGR of 8.5% over the forecast period. According to WHO, about 1 in 5 people develop cancer in their lifetime. This is expected to be the propelling factor for testing by healthcare professionals. Many countries are investing in facilities to curb increasing cancer cases which is anticipated to lead to the market growth of oncology testing.
The enzyme based immunoassay segment dominated the global immunoprotein diagnostic testing market in 2023 and it is expected to be retain its dominance during the forecast period. This is due to role of enzyme based immunoassay in diagnosing infectious diseases. Laboratories and healthcare services are undertaking automated diagnostic testing. Improvement in enzyme immunoassay technologies have improved test sensitivity, specificity and speed.
The chemiluminescence assay segment is expected to grow at CAGR of 8.7%. Chemiluminescence assay tests are widely used in the detection of chronic diseases, such as autoimmune disease, infectious disease, cardiovascular disease, obesity, diabetes and cancer. Chemiluminescence assay is also used by various pharmaceutical companies and research institutes for therapeutic drug monitoring. The increasing awareness about the early diagnosis of chronic diseases and the increasing drug research and development activities by pharmaceutical companies are considered to have a high impact on the market growth.
The hospitals and clinics dominated the market with a share of 45.14% in 2023. Hospitals and clinics cater to many patients on a daily basis, leading to a high demand for diagnostic testing services. Hospitals often have specialized departments and advanced medical equipment that enable them to provide accurate and timely immunoprotein diagnostic testing services. The shift from centralized testing to decentralized testing has propelled the growth of the market. Technological advancement in the healthcare sector also has propelled the market growth.
The diagnostic laboratories segment is expected to grow at a CAGR of 8. 7% during the forecast period. Diagnostic laboratories are expected to grow due to increased accessibility and speed and convenience for patients. Awareness about the importance of early diagnosis in chronic condition is driving the market growth.
The retail sales segment dominated the market with a revenue share of 54.11% in 2023. This can be attributed to accessibility and convenience for the patients. Retail sales make immunoprotein diagnostic tests readily available to individuals. Also, retail sales offer convenient access to immunoprotein diagnostic tests enabling patients to take control of their health. They play a crucial role in raising awareness about the importance of diagnostic testing among the general population, driving market growth.
The direct tender segment is expected to grow at a CAGR of 7.8% during the forecast period. Direct tender offers a streamlined process of procurement for healthcare facilities and institutions where the demand for these tests is in big volume. This direct tender arrangement often results in cost savings for buyers due to bulk purchasing and negotiated pricing which makes it an attractive option for healthcare providers. Also, direct tender arrangements allow for the customization of products and services based on the specific needs of healthcare providers.
North America dominated the market with a revenue share of 42.85% in 2023. It is attributable to technological advancements, high prevalence of chronic diseases and increasing research and development investments. The region has well established healthcare infrastructure with advanced medical facilities, skilled healthcare professionals, and robust regulatory frameworks. This facilitates easy access to immunoprotein diagnostic testing services for patients, contributing to the market dominance.
U.S. Immunoprotein Diagnostic Testing Market Trends
The U.S immunoprotein diagnostic testing market dominated the North America market with a share of 78.1% in 2023. The increasing prevalence of chronic diseases, such as cancer, cardiovascular diseases, and autoimmune disorders, in the U.S. drives the demand for immunoprotein diagnostic testing to aid in early detection and monitoring of these conditions. Also, the U.S. has stringent regulatory standards enforced by agencies like the United States Food and Drug Administration, ensuring the quality and safety of diagnostic tests, which enhances consumer trust and confidence in the market.
Europe Immunoprotein Diagnostic Testing Market Trends
The Europe immunoprotein diagnostic testing market is expected to witness significant growth driven by factors such as the increasing prevalence of chronic diseases in the region, technological advancements, growing geriatric population, focus on personalized medicine, government initiatives and rising healthcare expenditure. These key drivers are shaping the landscape of immunoprotein diagnostic testing in Europe, leading to improved patient care and outcomes.
The UK immunoprotein diagnostic testing market is expected to grow significantly in the coming years due to increasing awareness and improved diagnosis methods. Government organizations such as National Health Services UK are taking initiatives such as NHS long term plan with goals to protect people from cancer.
The Germany immunoprotein diagnostic testing market held a substantial market share in 2023 owing to the increasing geriatric population and need for personalized medicine and treatment. Immunoprotein tests help healthcare providers to determine individualized treatment plans based on a patient’s specific protein markers, driving the market growth.
Asia Pacific Immunoprotein Diagnostic Testing Market Trends
Asia Pacific immunoprotein diagnostic testing market is anticipated to witness the fastest CAGR of 9.9% in the coming years. This growth is due to increasing investment in the healthcare industry by government and private companies. The increasing geriatric population in the region and government initiatives to spread awareness and control diseases such as cancer, HIV and other infectious diseases are propelling the market growth in the region.
The Japan immunoprotein diagnostic testing market is expected to witness significant growth during the forecast period, 2024 to 2033 owing to the improved diagnosis methods and technological advancements.
India is to expect to witness growth in immunoprotein diagnostic testing market over the forecast period due to increasing prevalence of Cancer and HIV diseases. According to the National Aids Control Organization there are more than 24 lakh people living with HIV in 2022.
The following are the leading companies in the immunoprotein diagnostic testing market. These companies collectively hold the largest market share and dictate industry trends.
This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Nova one advisor, Inc. has segmented the Immunoprotein Diagnostic Testing market.
By Test
By Application
By Technology
By End Use
By Distribution Channel
By Region
Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Immunoprotein Diagnostic Testing Market Variables, Trends, & Scope
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. Immunoprotein Diagnostic Testing Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
3.4.1.2. Bargaining power of the buyers
3.4.1.3. Threats of substitution
3.4.1.4. Threats from new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Economic and Social landscape
3.4.2.3. Technological landscape
3.4.2.4. Environmental landscape
3.4.2.5. Legal landscape
Chapter 4. Immunoprotein Diagnostic Testing Market: Test Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Immunoprotein Diagnostic Testing Market: Test Movement Analysis, USD Million, 2023 & 2030
4.3. Complement System Proteins Diagnostic Tests
4.3.1. Complement System Proteins Diagnostic Tests Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.4. Free Light Chain Diagnostic Tests
4.4.1. Free Light Chain Diagnostic Tests Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5. Haptoglobin Diagnostic Tests
4.5.1. Haptoglobin Diagnostic Tests Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.6. Immunoglobulin Diagnostic Tests
4.6.1. Immunoglobulin Diagnostic Tests Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.7. Prealbumin Diagnostic Tests
4.7.1. Prealbumin Diagnostic Tests Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.8. C-Reactive Protein (CRP) Diagnostic Tests
4.8.1. C-Reactive Protein (CRP) Diagnostic Tests Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 5. Immunoprotein Diagnostic Testing Market: Application Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Immunoprotein Diagnostic Testing Market: Application Movement Analysis, USD Million, 2023 & 2030
5.3. Infectious Disease Testing
5.3.1. Infectious Disease Testing Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.4. Oncology Testing
5.4.1. Oncology Testing Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.5. Endocrine Testing
5.5.1. Endocrine Testing Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.6. Toxicology Testing
5.6.1. Toxicology Testing Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.7. Allergy Testing
5.7.1. Allergy Testing Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.8. Autoimmune Disease Testing
5.8.1. Autoimmune Disease Testing Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 6. Immunoprotein Diagnostic Testing Market: Technology Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Immunoprotein Diagnostic Testing Market: Technology Movement Analysis, USD Million, 2023 & 2030
6.3. Radioimmunoassay
6.3.1. Radioimmunoassay Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.4. Enzyme Based Immunoassay
6.4.1. Enzyme Based Immunoassay Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5. Chemiluminescence Assay
6.5.1. Chemiluminescence Assay Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6. Immunofluorescence Assay
6.6.1. Immunofluorescence Assay Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.7. Immunoturbidity Assay
6.7.1. Immunoturbidity Assay Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.8. Immunoprotein Electrophoresis
6.8.1. Immunoprotein Electrophoresis Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 7. Immunoprotein Diagnostic Testing Market: End Use Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. Immunoprotein Diagnostic Testing Market: Material Movement Analysis, USD Million, 2023 & 2030
7.3. Hospitals and Clinics
7.3.1. Hospitals and Clinics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
7.4. Diagnostic Laboratories
7.4.1. Diagnostic Laboratories Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5. Others
7.5.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 8. Immunoprotein Diagnostic Testing Market: Distribution Channel Estimates & Trend Analysis
8.1. Segment Dashboard
8.2. Immunoprotein Diagnostic Testing Market: Distribution Channel Movement Analysis, USD Million, 2023 & 2030
8.3. Direct Tender
8.3.1. Direct Tender Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
8.4. Retail Sales
8.4.1. Retail Sales Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 9. Immunoprotein Diagnostic Testing Market: Regional Estimates & Trend Analysis
9.1. Immunoprotein Diagnostic Testing Market Share, By Region, 2023 & 2030, USD Million
9.2. North America
9.2.1. North America Immunoprotein Diagnostic Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
9.2.2. U.S.
9.2.2.1. U.S. Immunoprotein Diagnostic Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
9.2.3. Canada
9.2.3.1. Canada Immunoprotein Diagnostic Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
9.2.4. Mexico
9.2.4.1. Mexico Immunoprotein Diagnostic Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
9.3. Europe
9.3.1. Europe Immunoprotein Diagnostic Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
9.3.2. UK.
9.3.2.1. UK Immunoprotein Diagnostic Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
9.3.3. Germany
9.3.3.1. Germany Immunoprotein Diagnostic Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
9.3.4. France
9.3.4.1. France Immunoprotein Diagnostic Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
9.3.5. Italy
9.3.5.1. Italy Immunoprotein Diagnostic Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
9.3.6. Spain
9.3.6.1. Spain Immunoprotein Diagnostic Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
9.3.7. Norway
9.3.7.1. Norway Immunoprotein Diagnostic Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
9.4. Asia Pacific
9.4.1. Asia Pacific Immunoprotein Diagnostic Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
9.4.2. China
9.4.2.1. China Immunoprotein Diagnostic Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
9.4.3. India
9.4.3.1. India Immunoprotein Diagnostic Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
9.4.4. Japan
9.4.4.1. Japan Immunoprotein Diagnostic Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
9.4.5. Australia
9.4.5.1. Australia Immunoprotein Diagnostic Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
9.4.6. South Korea
9.4.6.1. South Korea Immunoprotein Diagnostic Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
9.4.7. Thailand
9.4.7.1. Thailand Immunoprotein Diagnostic Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
9.5. Latin America
9.5.1. Latin America Immunoprotein Diagnostic Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
9.5.2. Brazil
9.5.2.1. Brazil Immunoprotein Diagnostic Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
9.5.3. Argentina
9.5.3.1. Argentina Immunoprotein Diagnostic Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
9.6. Middle East and Africa
9.6.1. Middle East and Africa Immunoprotein Diagnostic Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
9.6.2. South Africa
9.6.2.1. South Africa Immunoprotein Diagnostic Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
9.6.3. Saudi Arabia
9.6.3.1. Saudi Arabia Immunoprotein Diagnostic Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
9.6.4. UAE
9.6.4.1. UAE Immunoprotein Diagnostic Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
9.6.5. Kuwait
9.6.5.1. Kuwait Immunoprotein Diagnostic Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 10. Competitive Landscape
10.1. Recent Developments & Impact Analysis by Key Market Participants
10.2. Company Categorization
10.3. Company Heat Map Analysis
10.4. Company Profiles
10.4.1. Agilent Technologies, Inc.
10.4.1.1. Participant’s Overview
10.4.1.2. Financial Performance
10.4.1.3. Product Benchmarking
10.4.1.4. Recent Developments/ Strategic Initiatives
10.4.2. Danaher Corporation.
10.4.2.1. Participant’s Overview
10.4.2.2. Financial Performance
10.4.2.3. Product Benchmarking
10.4.2.4. Recent Developments/ Strategic Initiatives
10.4.3. Thermo Fisher Scientific Inc.
10.4.3.1. Participant’s Overview
10.4.3.2. Financial Performance
10.4.3.3. Product Benchmarking
10.4.3.4. Recent Developments/ Strategic Initiatives
10.4.4. PerkinElmer Inc.
10.4.4.1. Participant’s Overview
10.4.4.2. Financial Performance
10.4.4.3. Product Benchmarking
10.4.4.4. Recent Developments/ Strategic Initiatives
10.4.5. Bio-Rad Laboratories, Inc.
10.4.5.1. Participant’s Overview
10.4.5.2. Financial Performance
10.4.5.3. Product Benchmarking
10.4.5.4. Recent Developments/ Strategic Initiatives
10.4.6. Aurora Biomed Inc.
10.4.6.1. Participant’s Overview
10.4.6.2. Financial Performance
10.4.6.3. Product Benchmarking
10.4.6.4. Recent Developments/ Strategic Initiatives
10.4.7. Tecan Trading AG
10.4.7.1. Participant’s Overview
10.4.7.2. Financial Performance
10.4.7.3. Product Benchmarking
10.4.7.4. Recent Developments/ Strategic Initiatives
10.4.8. Promega Corporation.
10.4.8.1. Participant’s Overview
10.4.8.2. Financial Performance
10.4.8.3. Product Benchmarking
10.4.8.4. Recent Developments/ Strategic Initiatives
10.4.9. Charles River Laboratories
10.4.9.1. Participant’s Overview
10.4.9.2. Financial Performance
10.4.9.3. Product Benchmarking
10.4.9.4. Recent Developments/ Strategic Initiatives
10.4.10. Creative Biolabs
10.4.10.1. Participant’s Overview
10.4.10.2. Financial Performance
10.4.10.3. Product Benchmarking
10.4.10.4. Recent Developments/ Strategic Initiatives
Cross-segment Market Size and Analysis for Mentioned Segments
Additional Company Profiles
(Upto 5 With No Cost)
Additional Countries (Apart
From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers